glaxosmithkline stock price

by Rosemarie Roob Published 3 years ago Updated 2 years ago

Is GlaxoSmithKline plc stock a buy?

GlaxoSmithKline plc (NYSE:GSK) is 0.59% up. Looking at the short shares, we see there were 20.46 million shares sold at short interest cover period of 5.36 days. The consensus price target for the stock as assigned by Wall Street analysts is $43.06 ...

When does GSK pay dividend?

GSK Study Register and patient level data
Clinical trial phases
Become a clinical research volunteer
Data transparency
Compassionate use (Expanded access)

How does dividend affect stock and option prices?

You have three possible courses of action:

Do nothing (hold the option),
Exercise the option early, or
Sell the option and buy 100 shares of stock.

Does a stock have value without a dividend?

The reality is that without a dividend the company is giving nothing back to the shareholders. The value Growth stock companies is just a piece of paper. These companies choose not to give out dividends to invest in the business. This generally leads to capital appreciation for the investor.

See more

When will GlaxoSmithKline release its next quarterly earnings?

How much does GlaxoSmithKline make?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, July 28th 2021. View our earnings forecast for GlaxoSmithKline.

What is the dividend payout ratio for GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of $105.63 billion and generates $43.79 billion in revenue each year. The pharmaceutical company earns $7.38 billion in net income (profit) each year or $2.98 on an earnings per share basis.

How much is GSK stock worth in 2020?

Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 69.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. View GlaxoSmithKline's dividend history.

London Stock Exchange

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GSK stock has decreased by 1.6% and is now trading at $39.23. View which stocks have been most impacted by COVID-19.

Environmental, Social, and Governance Rating

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Business Summary

"A" score indicates excellent relative ESG performance and a high degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.

News